Search
- Oct 9, 2023
An investor’s perspective on health tech with a16z’s Vineeta Agarwala at #HLTH2023
Dr. Agarwala gives an intro to the health tech space, describes what areas interest her, and rates the current funding environment.
Also look for unique social pages for BiotechTV U.
#1. Ultragenyx's Emil Kakkis on Angelman syndrome data, rare disease treatment modalities, and more
#2. The CEO of Madrigal on the launch of Rezdiffra for NASH liver disease
#3. Sutro Biopharma's CEO on ADCs, non-cell protein synthesis, and more
#4. Verve Therapeutics' CEO on today's gene editing clinical trial pause
#5. Daphne Zohar on becoming the CEO of Seaport Therapeutics and a $100M series A